Erica Acquarone et al. 2019
Featured Research: Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model
Tien-Phat V. Huynh, Chao Wang […] David M. Holtzman
Do et al. 2019
Featured Review: Glucocerebrosidase and its relevance to Parkinson disease
Jenny Do, Cindy McKinney, Pankaj Sharma & Ellen Sidransky
Masato et al. 2019
Featured Review: Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Anna Masato, Nicoletta Plotegher, Daniela Boassa & Luigi Bubacco
Gallardo et al. 2019
Featured Research: Targeting tauopathy with engineered tau-degrading intrabodies
Gilbert Gallardo, Connie H. Wong, [...] David M. Holtzman
Articles
-
-
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
-
Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3
-
Targeting tauopathy with engineered tau-degrading intrabodies
-
Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model
-
Exosomal cell-to-cell transmission of alpha synuclein oligomers
-
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1polymorphisms
-
Drosophila melanogaster as a model organism for Alzheimer’s disease
-
The Alzheimer's disease β-secretase enzyme, BACE1
-
Fluid biomarkers in Alzheimer’s disease – current concepts
Editor highlights
About Us
The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Editors-in-Chief:
- Guojun Bu, Mayo Clinic, USA
- Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA
Register now for ICMN2020
The 6th International Conference on Molecular Neurodegeneration will focus on Glial and Vascular Contributions to Neurodegenerative Diseases.
Join us in Bangkok, Thailand on May 21-23 2020!
About | Program | Registration
News from Alzforum
-
Cell-Specific Enhancer Atlas Centers AD Risk in Microglia. Again.
16 November 2019
-
-
Dipeptide Repeat Proteins Don’t Directly Block Nuclear Transport
15 November 2019
Advertisement
Molecular Neurodegeneration is the official journal of the BrightFocus Foundation.
Follow
Annual Journal Metrics
-
Speed
45 days to first decision for reviewed manuscripts only
32 days to first decision for all manuscripts
139 days from submission to acceptance
15 days from acceptance to publication
Citation Impact
8.274 - 2-year Impact Factor
8.102 - 5-year Impact Factor
1.436 - Source Normalized Impact per Paper (SNIP)
3.988 - SCImago Journal Rank (SJR)
Usage
460,499 downloads
494 Altmetric mentions
Advertisement
